TAIMEI TECH

Taimei Medical staged a rally and pullback today, starting flat at HKD 6.71, climbing to an intraday high of HKD 7.18 (a new 52-week peak) before retreating to close at HKD 7.00, up only 4.31%. Recent share repurchases at HKD 6.01-6.42 and a planned buyback capped at HKD 11 provided near-term support. The company narrowed its FY2025 net loss by 52% to a per-share loss of HKD 0.0198 in Q4, while AI clinical platform orders surged, though revenue edged up just 0.76% to HKD 149 million. Year-to-date, the stock has surged 75.44%, well above its 20-day MA of HKD 5.56, but remains 2.5% below the 52-week high of HKD 7.18, with the PB at 3.17x. The afternoon pullback, however, signaled profit-taking near the peak.